Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:289467.
doi: 10.1155/2015/289467. Epub 2015 Apr 2.

A review of collagen cross-linking in cornea and sclera

Xiao Zhang  1 , Xiang-Chen Tao  1 , Jian Zhang  2 , Zhi-Wei Li  1 , Yan-Yun Xu  1 , Yu-Meng Wang  1 , Chun-Xiao Zhang  1 , Guo-Ying Mu  1
Affiliations
Review

A review of collagen cross-linking in cornea and sclera

Xiao Zhang et al. J Ophthalmol. 2015.

Erratum in

Abstract

Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment of keratoconus. Although its complications are encountered during clinical practice, such as infection inducing risk, minimal invasion merits a further investigation on its future application in clinical practice. Recently, collagen cross-linking in sclera shows a promising prospect. In present study, we summarized the representative studies describing the clinical and laboratory application of collagen cross-linking published in past decades and provided our opinion on the positive and negative results of cross-linking in the treatment of ophthalmic disorders.

PubMed Disclaimer

References

    1. Elsheikh A., Wang D., Brown M., Rama P., Campanelli M., Pye D. Assessment of corneal biomechanical properties and their variation with age. Current Eye Research. 2007;32(1):11–19. doi: 10.1080/02713680601077145. - DOI - PubMed
    1. Sady C., Khosrof S., Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochemical and Biophysical Research Communications. 1995;214(3):793–797. doi: 10.1006/bbrc.1995.2356. - DOI - PubMed
    1. Raiskup F., Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. principles. The Ocular Surface. 2013;11(2):65–74. doi: 10.1016/j.jtos.2013.01.002. - DOI - PubMed
    1. Wollensak G., Spoerl E., Wilsch M., Seiler T. Endothelial cell damage after riboflavin-ultraviolet—a treatment in the rabbit. Journal of Cataract and Refractive Surgery. 2003;29(9):1786–1790. doi: 10.1016/s0886-3350(03)00343-2. - DOI - PubMed
    1. Mazzotta C., Traversi C., Baiocchi S., et al. Corneal healing after riboflavin ultraviolet-a collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. The American Journal of Ophthalmology. 2008;146(4):527–533. doi: 10.1016/j.ajo.2008.05.042. - DOI - PubMed